Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)
3.170
+0.150 (4.97%)
Jun 23, 2026, 3:00 PM CST
SHA:603718 Market Cap
SHA:603718 has a market cap or net worth of 2.07 billion as of June 23, 2026. Its market cap has decreased by -55.04% in one year.
Market Cap
2.07B
Enterprise Value
1.82B
Revenue
173.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.17
Market Cap Chart
Since May 15, 2015, SHA:603718's market cap has decreased from 2.75B to 2.07B, a decrease of -24.77%. That is a compound annual growth rate of -2.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 2.07B | -48.33% |
| Dec 31, 2025 | 4.00B | -12.02% |
| Dec 31, 2024 | 4.55B | -35.48% |
| Dec 29, 2023 | 7.05B | 11.42% |
| Dec 30, 2022 | 6.32B | -35.82% |
| Dec 31, 2021 | 9.85B | 21.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novoprotein Scientific | 2.46B |
| Shanghai Model Organisms Center | 2.40B |
| Shanghai Universal Biotech | 2.24B |
| Shandong Sito Bio-technology | 2.20B |
| Suzhou Fushilai Pharmaceutical | 2.15B |
| Jilin Jian Yisheng Pharmaceutical | 2.14B |
| Zhejiang East Asia Pharmaceutical | 2.02B |
| Jiangsu CoWin Biotech | 1.98B |